Pathology/Lab Coding Alert

NCCI 10.2 Update:

Get the Scoop on Infectious Agent Bundling

You can only choose 1 code and 1 method If you want to report infectious agent detection codes with confidence, you'll need to maneuver edit pairs in the latest National Correct Coding Initiative (NCCI) edits, version 10.2. The new bundles reflect common practice -- you shouldn't report both a method and organism code or two different method codes for a single test -- but you'll have to know how to override the edits when you legitimately perform two separate services.

NCCI 10.2 took effect July 1. You can access the edits online at the CMS site http://www.cms.hhs.gov/physicians/cciedits/default.asp. Don't Bill Twice for a Single Method Think you can bill for antigen detection by immunofluorescent technique and bill separately for an immunofluorescent study? Think again. NCCI bundles code family CPT 87260 (Infectious agent antigen detection by immunofluorescent technique; ...) -- representing identification of 20 organisms from adenovirus to Varicella zoster - with both 88346 (Immunofluorescent study, each antibody; direct method) and 88347 (... indirect method).

Note: See "Infectious Agent Edits: Use Our Chart to Navigate NCCI Lingo" for a complete list of the bundled codes. Reason: "Infectious agent antigen detection codes in the CPT microbiology section are for tests performed on a primary source, such as serum or stool specimen, and describe both the lab method used and the organism identified," says Larry Small, MS, MT(ASCP), principal consultant with L. Small Associates, a clinical laboratory and anatomic pathology compliance operations and billing specialty company. "For a single test, you should select the single code that most precisely describes these two elements."

Exception: "If the lab performs two separate tests from two separate sources using the same methodology, you can report the appropriate CPT code for each test," Small says. For example, if the lab tests sputum for Pneumocystis carinii by direct fluorescent antibody (DFA) and on the same day the pathologist performs an IgG immunofluorescent antibody test on a lung biopsy specimen, you should report a separate code for each test. Report 87281 (Infectious agent antigen detection by immunofluorescent technique; Pneumocystis carinii) for the sputum lab test, and 88346 for the lung biopsy immunofluorescent study.

"Now that NCCI bundles these two codes, you'll have to use modifier -59 [Distinct procedural service] to override the edits when the lab performs the tests on two distinct specimen sources," says Stacey Hall, RHIT, CPC, CCS-P, director of corporate coding for Medical Management Professionals Inc., a national billing and management firm in Chattanooga, Tenn. Don't Bill Twice for a Single Organism How about billing together different codes for cytomegalovirus identification, such as 87271 (Infectious agent antigen detection by immunofluorescent technique; Cytomegalovirus, direct fluorescent antibody [DFA]) with 87495 (Infectious agent detection by nucleic acid [DNA or RNA]; [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Pathology/Lab Coding Alert

View All